Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: In June 2016, popular posts on social media claimed that “sea lice” had invaded beaches in Florida. As the term “sea lice” is not widespread, especially among social media users residing in the northern states, these messages were viewed with skepticism. However, these posts stemmed from genuine news articles: Purple flags are popping up all over the Florida panhandle as a nearly-invisible nuisance is causing a headache for beach-goers. Sea lice, also known as beach lice, have been confirmed in South Walton and Santa Rosa Beaches, and they may be moving west towards Alabama. Sea lice are virtually impossible to see underwater, making them difficult to track. They are known to get stuck underneath bathing suits and irritate the skin, causing a rash known as seabather’s eruption. The claim that these creatures have “invaded” the United States’ southern shores is something of an exaggeration, and may have led some to believe that this is a new phenomenon. Actually, the term “sea lice” has been used since at least the 1950s, although researchers preferred the term “seabather’s eruption” as there is an unrelated marine parasite known as a “sea louse”: The term “sea lice” apparently originated during the 1950s and was used by local U.S. residents in describing the condition. This popular term persisted, despite efforts by scientists to discourage use of such an inappropriate designation. Sea lice are actually small parasites that affect fish. While the term “sea lice” can refer to the larval form of several stinging marine creatures, seabather’s eruption is commonly caused by thimble jellyfish larvae: Seabather’s eruption is a rash that occurs when a swimmer is stung by marine life larvae. The condition has many names, including sealice, pika-pika, sea poisoning, sea critters, and ocean itch. Two types of marine life that generally cause this rash are: Thimble jellyfish (Linuche unguiculata). These are found seasonally in the water off the Florida coast and across the Caribbean. The jellyfish breed in the Caribbean throughout the summer, peaking in May. The larvae are barely visible, appearing like a speck of finely ground pepper.

A: "Florida beaches have been invaded with ""sea lice."
****
Q: The news release does not mention costs. While a new therapy may not have an established price, the release could have stated “no price is available for this drug.” What would be even better is some context for what women suffering from postpartum pay typically for counseling and medications. The release notes that  there was a reduction in depressive symptoms of 17 points for those on the drug, and 12.8 for those in the placebo group based on the Hamilton Depression Rating Scale. The absolute reduction in the rating scale is given for each group. This information would have been much more helpful if the release also clarified the magnitude of the scale and whether a 4.2-point difference is clinically meaningful. The release contains one somewhat vague sentence on harms. The most common (≥10% of subjects) adverse events following during brexanolone injection administration were headache, dizziness and somnolence. Readers would also be interested in details on whether the drug is safe for nursing infants. That’s not mentioned. The double-blinded randomized trials are described in detail and readers are able to judge the quality of the evidence. The published study includes an important limitation of the research that’s not mentioned in the release: The trials assessed women for only 30 days; the effects of the treatment beyond 30 days are “unknown.” There is no disease mongering. The release explains how common postpartum depression is worldwide. The release notes that Sage Therapeutics funded the research. Sage Therapeutics is the developer of brexanolone injection and sponsor of the trials. A New Drug Application is currently under review by the FDA and brexanolone injection has been granted Breakthrough Therapy Designation. The FDA has assigned a Prescription Drug User Fee Act target date of December 19, 2018. What the release doesn’t tell us is that both quoted researchers disclosed financial ties with Sage Therapeutics. This information was included in the studies published in the Lancet. SM-B reports personal fees from MedScape and grants from Sage Therapeutics, awarded to the University of North Carolina … DRR reports personal fees and has stock options in Sage Therapeutics…. The release mentions that women currently can receive antidepressants for postpartum depression, but that the new drug being studied goes to work relieving symptoms faster than traditional antidepressants — days rather than weeks. The release notes that the drug is currently under FDA review, with a decision on its approval expected by the end of the year. The release notes that the new drug would be a novel treatment for postpartum depression, if approved. There is no unjustifiable language.

A: Newly Published Results Show Investigational Treatment Brexanolone Consistently Reduced Depressive Symptoms Across Three Postpartum Depression Trials, Supporting Submission for FDA Approval
****
Q: Amid reports of Summitt’s failing health, her family issued a statement asking for prayers and saying that the 64-year-old Summitt is surrounded by the people who mean the most to her. It also asked for privacy. The statement was posted on the Pat Summitt Foundation’s website and was issued by Erin Freeman, a spokeswoman for the Summitt family. Former Tennessee player Tamika Catchings was flying to Knoxville to visit the coach instead of returning to Indiana with the WNBA’s Fever. Other former players were issuing support on Twitter through the “PrayForPat” hashtag. Phoenix Mercury center and Tennessee alum Isabelle Harrison said former Lady Volunteers players were keeping up with Summitt’s situation in a group text-message chain. “There are like 30 of us in a group chat right now talking, and people are flying into Knoxville and trying to see her,” Harrison said Sunday after the Mercury’s victory over the New York Liberty. “You just didn’t expect any of this to happen. Everyone’s trying to fill each other in with any information they have.” Harrison said she often went to Summitt’s home and rehabbed with her last year while recovering from a torn anterior cruciate ligament that ended the post player’s senior season at Tennessee prematurely. They also occasionally went to practice together. “I was at practice one day watching some of the girls, (and a) freshman took a fast shot,” Harrison said. ”(Summitt) looked at me and was like, ‘What was wrong was that?’ I was like, ‘She shot too quick.’ (She said), ‘Yeah, that’s right.’ (Summitt) still had it.” The update about Summitt’s condition brought a flood of support from throughout the sports world. An outpouring of concern on social media came from rival coaches such as South Carolina’s Dawn Staley, Notre Dame’s Muffet McGraw and Vanderbilt’s Stephanie White. Other sympathetic tweets came from sports figures as varied as Billie Jean King and Steve Spurrier. Summitt stepped down as Tennessee’s coach in 2012, one year after announcing her diagnosis of early onset dementia, Alzheimer’s type. She went 1,098-208 with eight national titles. She has the most career wins of any Division I men’s or women’s basketball coach. Since her diagnosis, Summitt has played a leading role in the fight against Alzheimer’s. She launched the Pat Summitt Foundation, which is dedicated to researching and educating people about the disease while also providing services to patients and caregivers. The Pat Summitt Alzheimer’s Clinic is scheduled to open at the University of Tennessee medical center in December. “When she fights this disease, what she has taught all of us is how to do it with courage,” former Tennessee women’s athletic director Joan Cronan said at a 2015 charity event honoring Summitt. “She’s done that from Day One. It’s been about (how) we can find a cure for this disease, and she has done it facing it straight-on and she’s done it giving back as she always has.” Summitt continues to hold a position as head coach emeritus of the Tennessee women’s basketball team. She attended nearly every home game and many practices in the first year after stepped down as coach, though she had a less visible role in subsequent seasons. She cut back on public appearances in recent years. --- AP Basketball Writer Doug Feinberg in New York contributed to this report.

A:
Past few days ‘difficult’ for former Tennessee coach Summitt.
****